BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

Despite widespread public health warnings and media attention focused on the dangers of opioid ... designed a cannabinoid ...

The result is a three-dimensional Fourier, or electron-density, map of the unit cell, which for the first time reveals the general nature of the tertiary structure of a protein molecule.

Q. What should I do if my media ground pass is stolen or missing? A. If your media ground pass is lost or stolen, you MUST immediately report it to the Media Accreditation Office (located at the ...

The authors note that, due to a production error, Fig. 5 appears incorrectly. In panel E, the pink label “TβRI” should be corrected to “TβRII.” The corrected figure and its legend appear below. The ...

Combine the power of Canada’s largest media brands across multiple platforms to multiple target groups. Discover Bell Media’s three conventional networks led by CTV, Canada’s #1 television channel, ...

Small molecule drugs, which include pills, capsules and creams, make up more than 90% of all prescriptions and two-thirds of new drug approvals annually. Yet, under the IRA, they face stricter ...

Credit: Alexey Krav/Shutterstock. Distributed energy resource management provider Enersponse and Molecule Systems have teamed up to enhance virtual power plant (VPP) capabilities for commercial and ...

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China State Key Laboratory of Radiation Medicine and Protection, School for Radiological and ...

The partnership is set to discover and optimise small molecule compounds required for the targets. Credit: totojang1977/Shutterstock. Incyte and Genesis Therapeutics ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its ...

Interim results from the first two cohorts of its Phase Ib trial that saw its once daily oral small molecule GLP-1 receptor demonstrating a 6.3% cut in body weight. Credit: Shutterstock / Jelena ...